Direct cleavage, proteasomal degradation and sequestration: Three mechanisms of viral subversion of type i interferon responses

Journal of Innate Immunity

Volumn 1, Issue 6, 2009, Pages 599-606

  McInerney, Gerald M ^a   Karlsson Hedestam, Gunilla B ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

Infection; Innate immunity; Interferon ; Virus

Indexed keywords

ALPHA INTERFERON; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; PROTEIN KINASE TYK2; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; VIRUS PROTEIN; VIRUS RNA;

HUMAN; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; RNA REPLICATION; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS RESISTANCE;

ANIMALS; HUMANS; INTERFERON TYPE I; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS DISEASES; VIRUSES;

EID: 70350304279     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000235861     Document Type: Short Survey

References (68)

1. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434: 772-777.
2. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M: Functional role of type I and type II interferons in antiviral defense. Science 1994; 264: 1918-1921.
3. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T: Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN- - / - gene induction. Immunity 2000; 13: 539-548.
4. Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, Yang K, Chapgier A, Eidenschenk C, Eid P, Al Ghonaium A, Tufenkeji H, Frayha H, Al-Gazlan S, Al- Rayes H, Schreiber RD, Gresser I, Casanova JL: Impaired response to interferon- - / - and lethal viral disease in human STAT1 deficiency. Nat Genet 2003; 33: 388-391.
5. Fazakerley JK, Boyd A, Mikkola ML, Kaariainen L: A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus. J Virol 2002; 76: 392-396.
6. Wang F, Ma Y, Barrett JW, Gao X, Loh J, Barton E, Virgin HW, McFadden G: Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nat Immunol 2004; 5: 1266-1274.
7. Haller O, Kochs G, Weber F: The interferon response circuit: Induction and suppression by pathogenic viruses. Virology 2006; 344: 119-130.
8. Hiscott J, Nguyen TL, Arguello M, Nakhaei P, Paz S: Manipulation of the nuclear factor- - B pathway and the innate immune response by viruses. Oncogene 2006; 25: 6844-6867.
9. Randall RE, Goodbourn S: Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008; 89: 1-47.
10. Breakwell L, Dosenovic P, Karlsson Hedestam GB, D'Amato M, Liljestrom P, Fazakerley J, McInerney GM: Semliki Forest virus nonstructural protein 2 is involved in suppression of the type I interferon response. J Virol 2007; 81: 8677-8684.
11. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE: The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, MDA-5, and inhibit its activation of the IFN- - promoter. Proc Natl Acad Sci USA 2004; 101: 17264-17269.
12. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730-737.
13. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441: 101-105.
14. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S: IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005; 6: 981-988.
15. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J: Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437: 1167-1172.
16. Seth RB, Sun L, Ea CK, Chen ZJ: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF- - B and IRF 3. Cell 2005; 122: 669-682.
17. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB: VISA is an adapter protein required for virus-triggered IFN- - signaling. Mol Cell 2005; 19: 727-740.
18. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T: IKK - and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4: 491-496.
19. Chen ZJ: Ubiquitin signalling in the NF- - B pathway. Nat Cell Biol 2005; 7: 758-765.
20. Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, Parekh BS, Wathelet MG: Structure and function of the interferon- - enhanceosome. Cold Spring Harb Symp Quant Biol 1998; 63: 609-620.
21. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S: Cell typespecific involvement of RIG-I in antiviral response. Immunity 2005; 23: 19-28.
22. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF- - B by Toll-like receptor 3. Nature 2001; 413: 732-738.
23. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis ESC: Innate antiviral responses by means of TLR7-mediated recognition of single- stranded RNA. Science 2004; 303: 1529-1531.
24. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-1529.
25. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A: Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198: 513-520.
26. Colonna M, Krug A, Cella M: Interferonproducing cells: on the front line in immune responses against pathogens. Curr Opin Immunol 2002; 14: 373-379.
27. Kawai T, Akira S: Innate immune recognition of viral infection. Nat Immunol 2006; 7: 131-137. (Pubitemid 43135878)
28. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD: How cells respond to interferons. Annu Rev Biochem 1998; 67: 227-264.
29. Peng G, Lei KJ, Jin W, Greenwell-Wild T, Wahl SM: Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 2006; 203: 41-46.
30. Marie I, Durbin JE, Levy DE: Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. Embo J 1998; 17: 6660-6669.
31. Neznanov N, Chumakov KM, Neznanova L, Almasan A, Banerjee AK, Gudkov AV: Proteolytic cleavage of the p65-RelA subunit of NF- - B during poliovirus infection. J Biol Chem 2005; 280: 24153-24158.
32. Krausslich HG, Nicklin MJ, Toyoda H, Etchison D, Wimmer E: Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol 1987; 61: 2711-2718.
33. Clark ME, Lieberman PM, Berk AJ, Dasgupta A: Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol 1993; 13: 1232-1237.
34. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M, Jr., Lemon SM: Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005; 102: 2992-2997.
35. Lin R, Lacoste J, Nakhaei P, Sun Q, Yang L, Paz S, Wilkinson P, Julkunen I, Vitour D, Meurs E, Hiscott J: Dissociation of a MAVS/ IPS-1/VISA/Cardif- IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 2006; 80: 6072-6083. (Pubitemid 43849185)
36. Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, Lemon SM: Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci USA 2007; 104: 7253-7258.
37. Bhoj VG, Chen ZJ: Ubiquitylation in innate and adaptive immunity. Nature 2009; 458: 430-437.
38. Hoeller D, Dikic I: Targeting the ubiquitin system in cancer therapy. Nature 2009; 458: 438-444.
39. Yang Y, Yu X: Regulation of apoptosis: The ubiquitous way. FASEB J 2003; 17: 790-799.
40. Saira K, Zhou Y, Jones C: The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits - interferon promoter activity. J Virol 2007; 81: 3077-3086.
41. Barro M, Patton JT: Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc Natl Acad Sci USA 2005; 102: 4114-4119.
42. Seago J, Hilton L, Reid E, Doceul V, Jeyatheesan J, Moganeradj K, McCauley J, Charleston B, Goodbourn S: The N pro product of classical swine fever virus and bovine viral diarrhea virus uses a conserved mechanism to target interferon regulatory factor-3. J Gen Virol 2007; 88: 3002-3006.
43. Hilton L, Moganeradj K, Zhang G, Chen YH, Randall RE, McCauley JW, Goodbourn S: The N Pro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J Virol 2006; 80: 11723-11732.
44. Didcock L, Young DF, Goodbourn S, Randall RE: The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 1999; 73: 9928-9933.
45. Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, Lamb RA, Horvath CM: The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 2001; 283: 230-239.
46. Ulane CM, Rodriguez JJ, Parisien JP, Horvath CM: STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol 2003; 77: 6385-6393.
47. Andrejeva J, Poole E, Young DF, Goodbourn S, Randall RE: The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J Virol 2002; 76: 11379-11386.
48. Ulane CM, Kentsis A, Cruz CD, Parisien JP, Schneider KL, Horvath CM: Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain. J Virol 2005; 79: 10180-10189.
49. Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF: Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003; 302: 1056-1060.
50. Holmes RK, Malim MH, Bishop KN: APOBEC- mediated viral restriction: not simply editing? Trends Biochem Sci 2007; 32: 118-128.
51. Chang HW, Watson JC, Jacobs BL: The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 1992; 89: 4825-4829.
52. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A: Influenza A virus NS1 protein prevents activation of NF- - B and induction of - / - interferon. J Virol 2000; 74: 11566-11573. (Pubitemid 32222305)
53. Hatada E, Fukuda R: Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 1992; 73: 3325-3329.
54. Watson JC, Chang HW, Jacobs BL: Characterization of a vaccinia virus-encoded double- stranded RNA-binding protein that may be involved in inhibition of the doublestranded RNA-dependent protein kinase. Virology 1991; 185: 206-216.
55. Chang HW, Uribe LH, Jacobs BL: Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. J Virol 1995; 69: 6605-6608.
56. Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T: Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 2000; 74: 6203-6206. (Pubitemid 30412995)
57. Davies MV, Elroy-Stein O, Jagus R, Moss B, Kaufman RJ: The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA- activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 1992; 66: 1943-1950.
58. Tait SW, Reid EB, Greaves DR, Wileman TE, Powell PP: Mechanism of inactivation of NF- - B by a viral homologue of I - B - . Signal-induced release of I - B - results in binding of the viral homologue to NF- - B. J Biol Chem 2000; 275: 34656-34664.
59. Li S, Labrecque S, Gauzzi MC, Cuddihy AR, Wong AH, Pellegrini S, Matlashewski GJ, Koromilas AE: The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 1999; 18: 5727-5737.
60. Symons JA, Alcami A, Smith GL: Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 1995; 81: 551-560.
61. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A: Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009; 5: 439-449.
62. Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, Burrows JF, Buick R, Stevenson NJ, Touzelet O, Gadina M, Power UF, Johnston JA: Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol 2007; 81: 3428-3436.
63. Paulus C, Krauss S, Nevels M: A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci USA 2006; 103: 3840-3845.
64. Lin W, Kim SS, Yeung E, Kamegaya Y, Blackard JT, Kim KA, Holtzman MJ, Chung RT: Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol 2006; 80: 9226-9235.
65. Wu M, Xu Y, Lin S, Zhang X, Xiang L, Yuan Z: Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J Gen Virol 2007; 88: 3260-3269.
66. Rodriguez JJ, Wang LF, Horvath CM: Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 2003; 77: 11842-11845.
67. Nanda SK, Baron MD: Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. J Virol 2006; 80: 7555-7568.
68. Mann BA, Huang JH, Li P, Chang HC, Slee RB, O'Sullivan A, Anita M, Yeh N, Klemsz MJ, Brutkiewicz RR, Blum JS, Kaplan MH: Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. J Interferon Cytokine Res 2008; 28: 367-380.